Literature DB >> 19254485

Performance of serological tests for syphilis in sexually transmitted diseases clinics in Guangxi Autonomous Region, China: implications for syphilis surveillance and control.

Yue-Ping Yin1, Wan-Hui Wei, Hong-Chun Wang, Bang-Yong Zhu, Yan-Hua Yu, Xiang-Sheng Chen, Rosanna W Peeling, Myron S Cohen.   

Abstract

BACKGROUND: China is experiencing a growing syphilis epidemic. Individuals are currently screened and cases are confirmed using traditional serological testing methods.
METHODS: A total of 11 558 serum specimens from patients at 14 sexually transmitted diseases (STD) clinics at provincial, prefecture and county levels in Guangxi Autonomous Region were tested at local clinics using the toluidine red unheated serum test (TRUST) and the SD Bioline Syphilis 3.0 Treponema Pallidum (SD-TP) test and then transported to the National STD Reference Laboratory for TRUST and confirmatory Treponema pallidum particle assay (TPPA) testing.
RESULTS: In local clinics, 13.2% of specimens were TRUST positive and 12.8% were TRUST and SD-TP positive. At the Reference Laboratory, 15.4% of specimens were TRUST positive and 11.8% were TRUST and TPPA positive. Local clinics showed a significantly higher prevalence of active syphilis compared with results from the Reference Laboratory (12.8 v. 11.8%, chi(2) = 4.59, P = 0.03). The local TRUST tests had consistent results with Reference Laboratory tests qualitatively among 96.2% of the specimens and quantitatively among 95.5% of the specimens. The algorithm of TRUST screening and then SD-TP confirmation among positive TRUST specimens at local STD clinics had 96.6% sensitivity and 99.3% specificity in diagnosing active syphilis compared with the 'gold standard' based on TRUST and TPPA positivity at the Reference Laboratory (positive predictive value 95.1% and negative predictive value 99.5%).
CONCLUSION: The TRUST screening and SD-TP confirmation in combination can be used at local STD clinics for the efficient diagnosis of serologically active syphilis. However, continuing capacity building and quality assurance remain critical in ensuring the quality of syphilis diagnosis at local clinics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254485     DOI: 10.1071/sh08027

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  6 in total

1.  Evaluation of rapid syphilis tests in KwaZulu-Natal.

Authors:  Nomonde Ritta Dlamini; Rogerio Phili; Cathy Connolly
Journal:  J Clin Lab Anal       Date:  2014-01-02       Impact factor: 2.352

Review 2.  China's syphilis epidemic: epidemiology, proximate determinants of spread, and control responses.

Authors:  Joseph D Tucker; Myron S Cohen
Journal:  Curr Opin Infect Dis       Date:  2011-02       Impact factor: 4.915

3.  VEGFA Involves in the Use of Fluvastatin and Zoledronate Against Breast Cancer.

Authors:  Haihong Pu; Qingyuan Zhang; Chunbo Zhao; Lei Shi; Yan Wang; Jingxuan Wang; Minghui Zhang
Journal:  Pathol Oncol Res       Date:  2017-07-25       Impact factor: 3.201

4.  Anti-hypertensive effect of Lycium barbarum L. with down-regulated expression of renal endothelial lncRNA sONE in a rat model of salt-sensitive hypertension.

Authors:  Xinyu Zhang; Xinping Yang; Yahui Lin; Miaomiao Suo; Ling Gong; Jingzhou Chen; Rutai Hui
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 5.  Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality.

Authors:  Hannah Blencowe; Simon Cousens; Mary Kamb; Stuart Berman; Joy E Lawn
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

6.  The Distribution of Syphilis Among Inpatients in Wenzhou, China: A Hospital Based Study.

Authors:  Ke Xu; Shengying Chi; Bin Chen; Lingzhi Chen; Dongyun Zheng
Journal:  Jundishapur J Microbiol       Date:  2016-03-05       Impact factor: 0.747

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.